Andropause - lessons from the European Male Ageing Study

Annales d'Endocrinologie

Volumn 75, Issue 2, 2014, Pages 128-131

  Huhtaniemi, Ilpo T ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Ageing; Late onset hypogonadism; Serum testosterone; Sexual function

Indexed keywords

TESTOSTERONE;

AGING; ANDROGEN THERAPY; ANDROPAUSE; ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; EUROPE; HEALTH STATUS; HUMAN; HYPOGONADISM; LIFESTYLE MODIFICATION; MEN'S HEALTH; PATHOGENESIS; SEXUAL FUNCTION; WEIGHT CHANGE; WEIGHT GAIN; ADVERSE EFFECTS; AFFECT; AGED; BLOOD; EPIDEMIOLOGY; ERECTILE DYSFUNCTION; HORMONE SUBSTITUTION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIBIDO; LIFESTYLE; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUESTIONNAIRE; SECRETION (PROCESS); SLEEP INITIATION AND MAINTENANCE DISORDERS; SMOKING; STATISTICS AND NUMERICAL DATA; SYMPTOM ASSESSMENT; TESTIS;

AFFECT; AGED; ANDROPAUSE; CAUSALITY; COMORBIDITY; ERECTILE DYSFUNCTION; EUROPE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIBIDO; LIFE STYLE; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; OBESITY; QUESTIONNAIRES; SLEEP INITIATION AND MAINTENANCE DISORDERS; SMOKING; SYMPTOM ASSESSMENT; TESTIS; TESTOSTERONE;

EID: 84901271832     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2014.03.005     Document Type: Article

References (19)

1. Sartorius G., Spasevska S., Idan A., Turner L., Forbes E., Zamojska A., et al. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin Endocrinol 2012, 77:755-763.
2. Handelsman D.J. Global trends in testosterone prescribing, 2000-2011: expanding the spectrum of prescription drug misuse. Med J Aust 2013, 199:548-551.
3. Lee D.M., Pye S.R., Tajar A., O'Neill T.W., Finn J.D., Boonen S., et al. Cohort profile: the European male ageing Study. Int J Epidemiol 2013, 42:391-401.
4. Wang C., Nieschlag E., Swerdloff R., Behre H.M., Hellstrom W.J., Gooren L.J., et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Androl 2009, 32:1-10.
5. Bhasin S., Cunningham G.R., Hayes F.J., Matsumoto A.M., Snyder P.J., Swerdloff R.S., et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010, 95:2536-2559.
6. Chueh K.S., Huang S.P., Lee Y.C., Wang C.J., Yeh H.C., Li W.M., et al. The comparison of the aging male symptoms (AMS) scale and androgen deficiency in the aging male (ADAM) questionnaire to detect androgen deficiency in middle-aged men. J Androl 2012, 33:817-823.
7. Wu F.C., Tajar A., Beynon J.M., Pye S.R., Silman A.J., Finn J.D., et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010, 363:123-135.
8. Ly L.P., Sartorius G., Hull L., Leung A., Swerdloff R.S., Wang C., et al. Accuracy of calculated free testosterone formulae in men. Clin Endocrinol 2010, 73:382-388.
9. Corona G., Rastrelli G., Maggi M. Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. Best Pract Res Clin Endocrinol Metab 2013, 27:557-579.
10. Wu F.C., Tajar A., Pye S.R., Silman A.J., Finn J.D., O'Neill T.W., et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 2008, 93:2737-2745.
11. Tajar A., Forti G., O'Neill T.W., Lee D.M., Silman A.J., Finn J.D., et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab 2010, 95:1810-1818.
12. Araujo A.B., Dixon J.M., Suarez E.A., Murad M.H., Guey L.T., Wittert G.A. Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96:3007-3019.
13. Pye S.R., Huhtaniemi I.T., Finn J.D., Lee D.M., O'Neill T.W., Tajar A., et al. Late-onset hypogonadism and mortality in aging men. J Clin Endocrinol Metab 2013, [jc20132052].
14. Camacho E.M., Huhtaniemi I.T., O'Neill T.W., Finn J.D., Pye S.R., Lee D.M., et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol 2013, 168:445-455.
15. Tayek J.A., Heber D., Byerley L.O., Steiner B., Rajfer J., Swerdloff R.S. Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer. Metabolism 1990, 39:1314-1319.
16. Basaria S., Coviello A.D., Travison T.G., Storer T.W., Farwell W.R., Jette A.M., et al. Adverse events associated with testosterone administration. N Engl J Med 2010, 363:109-122.
17. Vigen R., O'Donnell C.I., Baron A.E., Grunwald G.K., Maddox T.M., Bradley S.M., et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013, 310:1829-1836.
18. Finkle W.D., Greenland S., Ridgeway G.K., Adams J.L., Frasco M.A., Cook M.B., et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PloS one 2014, 9:e85805.
19. Legros J.J., Meuleman E.J., Elbers J.M., Geurts T.B., Kaspers M.J., Bouloux P.M. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study. Eur J Endocrinol 2009, 160:821-831.